Analysen zu VINCI
06.06.24 | VINCI Buy | Jefferies & Company Inc. | |
04.06.24 | VINCI Buy | Jefferies & Company Inc. | |
28.05.24 | VINCI Buy | Deutsche Bank AG | |
17.05.24 | VINCI Overweight | JP Morgan Chase & Co. | |
17.05.24 | VINCI Buy | UBS AG | |
16.05.24 | VINCI Buy | Jefferies & Company Inc. | |
16.05.24 | VINCI Overweight | JP Morgan Chase & Co. | |
03.05.24 | VINCI Buy | UBS AG | |
03.05.24 | VINCI Kaufen | DZ BANK | |
30.04.24 | VINCI Buy | UBS AG | |
30.04.24 | VINCI Buy | Goldman Sachs Group Inc. | |
26.04.24 | VINCI Buy | Goldman Sachs Group Inc. | |
25.04.24 | VINCI Buy | UBS AG | |
17.04.24 | VINCI Buy | UBS AG | |
17.04.24 | VINCI Buy | Jefferies & Company Inc. | |
05.04.24 | VINCI Overweight | JP Morgan Chase & Co. | |
04.04.24 | VINCI Buy | UBS AG | |
22.03.24 | VINCI Overweight | JP Morgan Chase & Co. | |
18.03.24 | VINCI Overweight | JP Morgan Chase & Co. | |
15.03.24 | VINCI Buy | UBS AG | |
27.02.24 | VINCI Overweight | Barclays Capital | |
22.02.24 | VINCI Buy | Jefferies & Company Inc. | |
16.02.24 | VINCI Buy | UBS AG | |
15.02.24 | VINCI Overweight | JP Morgan Chase & Co. | |
14.02.24 | VINCI Buy | UBS AG | |
13.02.24 | VINCI Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
13.02.24 | VINCI Buy | Jefferies & Company Inc. | |
09.02.24 | VINCI Overweight | JP Morgan Chase & Co. | |
08.02.24 | VINCI Overweight | JP Morgan Chase & Co. | |
08.02.24 | VINCI Buy | Deutsche Bank AG | |
08.02.24 | VINCI Buy | UBS AG | |
07.02.24 | VINCI Buy | Jefferies & Company Inc. | |
07.02.24 | VINCI Overweight | JP Morgan Chase & Co. | |
01.02.24 | VINCI Buy | Jefferies & Company Inc. | |
25.01.24 | VINCI Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
22.01.24 | VINCI Overweight | JP Morgan Chase & Co. | |
17.01.24 | VINCI Overweight | JP Morgan Chase & Co. | |
16.01.24 | VINCI Buy | UBS AG | |
16.01.24 | VINCI Overweight | Barclays Capital | |
12.01.24 | VINCI Buy | UBS AG | |
11.01.24 | VINCI Overweight | JP Morgan Chase & Co. | |
11.01.24 | VINCI Buy | UBS AG | |
15.12.23 | VINCI Overweight | JP Morgan Chase & Co. | |
15.12.23 | VINCI Buy | UBS AG | |
14.12.23 | VINCI Buy | Jefferies & Company Inc. | |
13.12.23 | VINCI Overweight | JP Morgan Chase & Co. | |
12.12.23 | VINCI Buy | UBS AG | |
12.12.23 | VINCI Overweight | JP Morgan Chase & Co. | |
07.12.23 | VINCI Overweight | JP Morgan Chase & Co. | |
01.12.23 | VINCI Overweight | JP Morgan Chase & Co. |
Aktuelle Aktienanalysen
30.01.25 | Sartorius vz. Hold | Warburg Research | |
30.01.25 | Deutsche Bank Buy | Warburg Research | |
30.01.25 | Symrise Buy | Warburg Research | |
30.01.25 | PUMA Buy | Warburg Research | |
30.01.25 | ASML NV Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
30.01.25 | IONOS Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
30.01.25 | Akzo Nobel Buy | Deutsche Bank AG | |
30.01.25 | Sartorius vz. Hold | Deutsche Bank AG | |
30.01.25 | Volvo AB Buy | Deutsche Bank AG | |
30.01.25 | ASML NV Buy | Deutsche Bank AG | |
30.01.25 | Ericsson Neutral | JP Morgan Chase & Co. | |
30.01.25 | Diageo Neutral | JP Morgan Chase & Co. | |
30.01.25 | PUMA Neutral | JP Morgan Chase & Co. | |
30.01.25 | Nokia Market-Perform | Bernstein Research | |
30.01.25 | Sanofi Outperform | Bernstein Research | |
30.01.25 | STMicroelectronics Outperform | Bernstein Research | |
30.01.25 | Roche Outperform | Bernstein Research | |
30.01.25 | ABB Underperform | Bernstein Research | |
30.01.25 | LVMH Moet Hennessy Louis Vuitton Outperform | Bernstein Research | |
30.01.25 | T-Mobile US Market-Perform | Bernstein Research | |
30.01.25 | Schneider Electric Outperform | Bernstein Research | |
30.01.25 | Beiersdorf Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
30.01.25 | Sartorius vz. Neutral | Goldman Sachs Group Inc. | |
30.01.25 | Adyen B.V. Parts Sociales Buy | Goldman Sachs Group Inc. | |
30.01.25 | E.ON Buy | Goldman Sachs Group Inc. | |
30.01.25 | Nordea Bank Abp Registered Shs Buy | UBS AG | |
30.01.25 | Volvo AB Neutral | UBS AG | |
30.01.25 | ASML NV Overweight | JP Morgan Chase & Co. | |
30.01.25 | T-Mobile US Buy | UBS AG | |
30.01.25 | Deutsche Telekom Overweight | JP Morgan Chase & Co. | |
30.01.25 | EssilorLuxottica Neutral | UBS AG | |
30.01.25 | GSK Neutral | UBS AG | |
30.01.25 | Knorr-Bremse Buy | UBS AG | |
30.01.25 | SAP Overweight | JP Morgan Chase & Co. | |
30.01.25 | T-Mobile US Overweight | JP Morgan Chase & Co. | |
30.01.25 | Continental Buy | UBS AG | |
30.01.25 | AstraZeneca Neutral | UBS AG | |
30.01.25 | Hapag-Lloyd Underweight | JP Morgan Chase & Co. | |
30.01.25 | Nokia Overweight | JP Morgan Chase & Co. | |
30.01.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
30.01.25 | Roche Underweight | JP Morgan Chase & Co. | |
30.01.25 | DWS Group Overweight | JP Morgan Chase & Co. | |
30.01.25 | Assicurazioni Generali Buy | Goldman Sachs Group Inc. | |
30.01.25 | DWS Group Neutral | UBS AG | |
30.01.25 | ABB Neutral | UBS AG | |
30.01.25 | Roche Neutral | UBS AG | |
30.01.25 | Nokia Neutral | UBS AG | |
30.01.25 | Sanofi Buy | UBS AG | |
30.01.25 | Nordea Bank Abp Registered Shs Buy | Goldman Sachs Group Inc. | |
30.01.25 | Roche Sell | Goldman Sachs Group Inc. |